The Shift to Oral Route of Administration
While inhalation is the dominant route, the oral route of administration also holds a significant share of the Asthma and COPD Drugs market. Oral medications, such as tablets and capsules, are often used for long-term management and can include drugs like leukotriene modifiers. They are also essential for patients who may have difficulty using inhalers correctly, such as young children or the elderly. The convenience of oral administration can also improve patient adherence, though it may be associated with more systemic side effects compared to inhaled drugs. The market for oral medications is driven by a need for a diverse range of treatment options to suit different patient needs and preferences. This segment ensures that the Asthma and COPD Drugs Market provides a comprehensive set of choices for respiratory care.